BETHLEHEM, Pa.--(BUSINESS WIRE)--GlucoLight Corporation, a development-stage company focused on non-invasive, continuous blood glucose monitoring, today announced the closing of the second tranche of its “C” round financing. The amount of the second tranche was not disclosed. The Company had previously raised $2 million in the first tranche of the “C” round.
